Dr. Brad Bengtson offers patients natural results that do not appear operated or over-done. He is a lead investigator for the new Natrelle Style 410 Highly Cohesive Gel implant in the U.S., current Chairman of the Natrelle 410 Strategic Council and current and founding member of Allergan’s Executive Council. He is a patent holder of six medical devices, and a national and international educator and leader in breast aesthetic research, and has received the prestigious Tiffany Award for the Best Annual Research by the American Society for Aesthetic Plastic Surgery.
You can find patients’ reviews and comments for Dr. Bengtson.
Please fix the following input errors: